Sign up Australia
Proactive Investors - Run By Investors For Investors

AusCann Group Holdings in halt ahead of capital raising

The halt will remain in place until Friday 19th May 2017.
AusCann Group Holdings in halt ahead of capital raising
The medical cannabis company listed on the ASX in February 2017

AusCann Group Holdings (ASX:AC8) has entered into an ASX trading halt pending details regarding a capital raising.

The halt will remain in place until the opening of trade on Friday 19th May 2017, or earlier if an announcement will be made to the market.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full AC8 profile View Profile

AusCann Group Holdings Ltd Timeline

Related Articles

cannabis leaf and green tablets
October 30 2018
The company will now proceed with stage II of the human clinical trial.
Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
Woman holding cannabis leaf
October 16 2018
Canadian subsidiary Crystal Mountain is expanding its range of hydroponics equipment to meet expected demand.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use